-
SBI Healthcare Opportunities Fund Regular Growth
Equity healthcare
Overview ( as on 11/09/25 )
NAV
₹435.15
Last change
₹1.33 +0.0%
Fund Size (AUM)
3963.38 Cr
Performance
20.79% (5Y)
Fund Details
SBI Healthcare Opportunities Fund Regular Growth
as of 11/09/25
AUM
3963.38 Cr
Expense Ratio
1.93 %
Benchmark
BSE Healthcare TR INR
ISIN
INF200K01446
Fund Manager
Tanmaya Desai
Exit Load
0.5% if redeemed within 0-15 days
0% if redeemed after 15 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| SBI Healthcare Opportunities Fund Regular Growth | 4.41% | 26.27% | 20.79% |
| BSE Healthcare TR INR | 1.03% | 23.76% | 18.86% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
10.86% |
Divi's Laboratories Ltd |
6.81% |
Max Healthcare Institute Ltd Ordinary Shares |
6.12% |
Cipla Ltd |
4.81% |
Lupin Ltd |
4.02% |
Torrent Pharmaceuticals Ltd |
3.59% |
Mankind Pharma Ltd |
3.49% |
Fortis Healthcare Ltd |
3.45% |
Gland Pharma Ltd |
3.31% |
Krishna Institute of Medical Sciences Ltd |
3.2% |
Sector Allocation
Healthcare |
93.98% |
Basic Materials |
6.02% |
Asset Allocation
-
96%
Equity
-
4%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Growth
Equity healthcare-
Returns
-
21.78% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
21.08% (5Y)
-
-
SBI Healthcare Opportunities Growth
Equity healthcare-
Returns
-
20.79% (5Y)
-
-
SBI Healthcare Opportunities IDCW-R
Equity healthcare-
Returns
-
20.79% (5Y)
-
-
UTI Healthcare Growth
Equity healthcare-
Returns
-
19.25% (5Y)
-
-
UTI Healthcare IDCW-P
Equity healthcare-
Returns
-
19.25% (5Y)
-
